Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WellGen, Inc.

Latest From WellGen, Inc.

Nutrigenomics Start-Ups

Paths to commercialization are uncertain in nutrigenomics, an emerging science which seeks to identify gene-food interactions that differ among subpopulations and between individuals and to personalize diets to prevent disease.

BioPharmaceutical Platform Technologies

WellGen Inc.

These days, consumers reach for calcium-fortified orange juice to keep bones healthy, whole-grain Cheerios that reduce the risk of heart disease and cancer, and bags of walnuts that advertise Omega 3, for heart health. The founders of WellGen believe the time is right to push the frontier of food science into medicine. With a patent from Rutgers University, WellGen will screen food substances against genes implicated in diseases.

BioPharmaceutical Platform Technologies

Start-Up Previews (5/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Nutrigenomics, features profiles of AlphaGenics Inc., NutraGenomics Inc. and WellGen Inc. Plus these Start-Ups across Health Care: Crystalplex Corp., GlycoFi Inc., NDO Surgical Inc. and Serenex Inc.

See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register